SLU and WashU to Co-Host ICTS Big Data Research Symposium (Links to an external site)
Partnership Development and Sustainability Support Program (PDSS) 2022-2023 Awardees Announced
The Washington University Institute of Clinical and Translational Sciences announces five partnerships selected to receive funding through the 2022-2023 Partnership Development and Sustainability Support (PDSS) program. This funding program provides up to $10,000 to new and existing community-academic partnerships for a 10-month period. It enables partners to develop the trust, infrastructure, capacity and skills needed […]
ICTS Pilot Funding Drives Research on Neurodegenerative Diseases
Since the inception of the ICTS in 2007, pilot funding opportunities have provided investigators with support for promising and innovative translational research. Frequently, this pilot funding begets research and novel findings that assist investigators in applying for additional grant mechanisms. In 2019, Guoyan Zhao, PhD, assistant professor in the Department of Neuroscience at Washington University […]
SLU Pediatric Gastroenterologist Receives Grant to Improve Stomach Pain for Children with Cystic Fibrosis (Links to an external site)
ST. LOUIS – Dhiren Patel, MD, associate professor of pediatrics at SLU’s School of Medicine and SLUCare pediatric gastroenterologist, was awarded a $50,000 grant by the Institute of Clinical and Translational Sciences (ICTS), a Washington University-led research consortium, of which Saint Louis University is a member.
SLU Nurse Awarded Grant to Help African American Patients Manage High Blood Pressure (Links to an external site)
ST. LOUIS – Devita Stallings, PhD, RN to BSN program coordinator and associate professor of nursing at Saint Louis University’s Trudy Busch Valentine School of Nursing, was awarded a $50,000 grant by the Institute of Clinical and Translational Sciences (ICTS), a Washington University-led research consortium, of which Saint Louis University is a member.
Immune modulator drugs improved survival for people hospitalized with COVID-19 (Links to an external site)
A large randomized, placebo-controlled clinical trial led by the National Institutes of Health shows that treating adults hospitalized with COVID-19 with infliximab or abatacept – drugs widely used to treat certain autoimmune diseases – did not significantly shorten time to recovery but did substantially improve clinical status and reduce deaths.
Spotlight on Jennie H. Kwon, DO, MSCI (Links to an external site)
As an undergraduate double major in English and Biology, Jennie Kwon, DO, MSCI, might have had a hard time predicting her eventual career path. But, during her first semester in medical school, Kwon admitted she was “bit by the proverbial microbiology bug”. “I was truly fascinated by these organisms,” recalls Kwon. “And I knew immediately that […]
Inappropriate antibiotics for nonhospitalized kids cost US at least $74 million (Links to an external site)
Such prescriptions can cause complications including diarrhea, rashes
Davorka M. discusses work with refugees, effects of external and internal factors on mental health
Davorka Marovic-Johnson, MEd, NCC, LPC, had a long history of providing mental health services to refugee clients from around the globe before transitioning into private practice. The horrors of war and the stress of adjusting to a new country can have a lasting effect on mental health and physical health. Personal history Davorka came to […]
ICTS holds 4th annual Symposium; Announces CTSA funding renewal
The Washington University Institute of Clinical and Translational Sciences (ICTS) hosted their 4th annual Symposium and Poster Display on Friday, May 13, 2022. The theme “Making an Impact, Shaping the Future” focused on strategies to address equity and diversity challenges experienced by institutions across the national Clinical and Translational Science Awards (CTSA) network. The hybrid […]